Effect of Allicin against Ischemia/Hypoxia-Induced H9c2 Myoblast Apoptosis via eNOS/NO Pathway-Mediated Antioxidant Activity

Figure 6

Effect of allicin and L-NAME on the expression of (a) eNOS, (b) Bax, and (c) Bcl-2 in H9c2 cells, evaluated by Western blot. Four groups were evaluated: one group of H9c2 cells that were not treated with either allicin or L-NAME and were subjected to I/H, one group of H9c2 cells that were pretreated with 5 μM allicin and subjected to I/H, one group of H9c2 cells that were pretreated with 5 μM allicin and 200 μM L-NAME and subjected to I/H, and one group of H9c2 cells that were pretreated with 200 μM L-NAME and subjected to I/H. independent experiments. The data are expressed as mean ± SEM. , compared with I/H. I/H, ischemia/hypoxia; AL, allicin.

(a)

(b)

(c)